The combination of elevated long‑term yields (10‑yr at 4.67%) and stagnant real GDP creates a high cost‑of‑capital environment with limited demand growth, which is especially detrimental for Graham Corporation’s capital‑intensive operations that rely on steady revenue expansion to offset fixed‑cost pressures.
A further rise in the 10‑year Treasury to 5.0% would increase Graham's weighted average cost of capital by roughly 30 basis points; given its negative free cash flow and thin operating margin, this could push net income below breakeven within two quarters, forcing asset sales or dilutive financing.
CPI falling: β_change=+0.5462 means a 1‑point decline in CPI trend could cut revenue growth by ~0.55 pp, eroding the primary tailwind.
Rate decline: β_change=+0.3034 implies that a 100 bp rate drop would reduce growth by ~0.30 pp, removing a secondary boost.
CPI rising: The high level and change coefficients suggest each 1‑point CPI uptick can add ~0.35–0.55 pp to revenue growth, reinforcing GHM's inflation pass‑through advantage.
Mortgage rates climbing: β_change=+0.4086 for mortgage levels indicates that higher mortgage activity could lift growth by roughly 0.41 pp per unit increase.
Earnings beats are the strongest catalyst: a 5% EPS surprise historically yields a +2.3% jump, suggesting that positioning long ahead of earnings season can capture outsized upside when analysts underestimate GHM’s margin trajectory.
Rate‑sensitivity risk: a series of three consecutive 25 bps Fed hikes could compress GHM’s market cap by roughly 5% over six months (3 x -1.7% day‑of + partial reversal), emphasizing the need for duration hedges or protective puts during tightening cycles.
Downside risk is concentrated in the CPI‑falling (coeff = 0.546) and rates‑falling (coeff = 0.303) sensitivities, which together account for roughly 55% of the severe‑stress impact; the unemployment coefficient (–0.250) amplifies losses when labor markets deteriorate.
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-07-31 · finexus.net